How strategic CDMO partnerships accelerate therapy development

Advanced therapy developers increasingly rely on CDMOs to navigate complex manufacturing and regulatory challenges. This session examines the characteristics of successful partnerships, from early-stage engagement to commercial scale-up, highlighting how shared risk, transparency, and technical alignment drive progress and investor confidence.

Key takeaways:

• Identify best practices for selecting and evaluating CDMO partners
• Explore collaboration models that enable flexibility and scalability
• Assess how CDMOs support regulatory readiness and technology transfer
• Understand contract structures that balance innovation and risk
• Learn how strategic partnerships accelerate timelines and reduce costs